TREAT TO TARGET FOR CROHN’S DISEASE WITH ADALIMUMAB TREATMENT IS COST EFFECTIVE OVER 48 WEEKS: AN ECONOMIC ASSESSMENT OF THE CALM TRIAL

Remo Panaccione  1     Jean-Frederic Colombel  2     Peter Bossuyt  3     Milan Lukas  4     Filip Baert  5     T. Vanásek  6     Ahmet Danalıoğlu  7     Gottfried Novacek     Alessandro Armuzzi     Walter Reinisch     Scott Johnson     Matthew Davis     Ezequiel Neimark     Joel Petersson     Anne M. Robinson     Roopal B Thakkar     Wan-Ju Lee     Martha Skup    
1 University of Calgary,Calgary,Canada
2 Icahn School of Medicine at Mount Sinai,New York,United States of America
3 Imelda General Hospital,Bonheiden,Belgium
4 Charles University,Prague,Czech Republic
5 AZ Delta Roeselare-Menen,Menen,Belgium
6 Hepato-Gastroenterologie HK, s.r.o.,Hradec Králové,Czech Republic
7 Bezmialem Vakif University,İst

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing